Yuji Yata

Real world evidence of enfortumab vedotin in patients with advanced urothelial cancer: A multicenter observational study

Wataru Fukuokaya, Yuhei Koike, Yuji Yata et al. · International Journal of Urology · 2023 · 29 citations

Medicine, Oncology, Pharmacotherapy +17

Comparison of the efficacy of enfortumab vedotin between patients with metastatic urothelial carcinoma who were treated with avelumab or pembrolizumab: real-world data from a multi-institutional study in Japan

Yosuke Hirasawa, Takahiro Adachi, Takeshi Hashimoto et al. · Journal of Cancer Research and Clinical Oncology · 2024 · 21 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Comparison of neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma in real-world practice: a multicenter retrospective study

Kazuhiro Takahashi, Fumihiko Urabe, Yushi Suhara et al. · Japanese Journal of Clinical Oncology · 2023 · 13 citations

Medicine, Oncology, Surgery +17

Docetaxel versus abiraterone for metastatic hormone‐sensitive prostate cancer with focus on efficacy of sequential therapy

Takafumi Yanagisawa, Kenichi Hata, Shintaro Narita et al. · The Prostate · 2023 · 10 citations

Medicine, Oncology, Urology +17

Real-world outcomes of adjuvant immunotherapy candidates with upper tract urothelial carcinoma: results of a multicenter cohort study

Hirokazu Kagawa, Fumihiko Urabe, Yuria Kiuchi et al. · International Journal of Clinical Oncology · 2023 · 10 citations

Medicine, Oncology, Urology +17